FDA Refers Wellbutrin SR, Zyban To NIH For Pediatric Studies
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency also requests that the National Institutes of Health Foundation study Elan’s Zonegran and Genzyme’s Renagel in children. The drugs’ sponsors had declined written requests for pediatric trials.